Regulatory News
Wednesday, April 27, 2016
UPDATE 1-Valeant CEO to tell U.S. Senate he regrets raising heart drug prices
WASHINGTON, April 27 (Reuters) - Outgoing Valeant
Pharmaceuticals Chief Executive Michael Pearson plans
to tell a U.S. Senate panel on Wednesday that it was a "mistake"
to jack up the price of two...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment